QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 silo-pharma-awarded-contract-to-its-contract-research-organization-partner-amplifybio-for-ind-enabling-large-animal-glp-study-of-spc-15-for-ptsd

Amplify Bio to complete GLP study of SPC-15 Novel Intranasal TherapeuticSilo study advances SPC-15 towards first-in-human trial

 why-silo-pharma-stock-is-down-over-30

Silo Pharma shares are trading lower by 31% during Wednesday's session. The company announced it has entered into agreement...

 silo-pharma-submits-pre-investigational-nda-to-fda-for-spc-15-as-a-treatment-for-ptsd-and-anxiety

Clinical roadmap unveiled for novel and proprietary intranasal PTSD treatmentSARASOTA, FL, June 04, 2024 (GLOBE NEWSWIRE) -- Si...

 silo-pharma-reports-results-from-study-for-depression-treatment-remission-and-relapse-prevention

The study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent r...

 silo-pharma-announces-results-for-intranasal-ptsd-treatment

Silo Pharma, Inc. (NASDAQ: SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company foc...

 silo-pharma-set-to-acquire-exclusive-licensing-for-promising-alzheimers-disease-therapeutic-spc-14-shows-cognitive-and-stress-reduction-benefits-in-preclinical-models

SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) --  Si...

 citizens-and-2-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed lower by around 10 points on Monday. When insiders purchase or sell shares, it indicates their confi...